RESEARCH TRIANGLE PARK – TG Therapeutics, which has an office in the Triangle for years, reportedly is moving company headquarters to North Carolina from New York.
According to the label for its recently approved multiple sclerosis drug “Briumvi” the company is now based in Morrisville.
TG Therapeutics drug label
TG Therapeutics is publicly traded on the Nasdaq under the symbol TGTX.
The firm has some 200 employees and is actively recruiting for a number of open jobs.
It has not confirmed the relocation.
The Triangle Business Journal first reported the story.
The North Carolina Biotechnology Center’s business directory lists TG as having an office in Raleigh.
